CD40 and neoplasm: Measurement of malondialdehyde (MDA) as a lipid peroxidation marker indicated that RSL3 administration triggered lipid oxidation production in tumor tissues, but this effect was remarkably abolished by treatment of anti-CD40 neutralizing antibody (Fig. 6J).